1h Free Analyst Time
The kidney stones therapeutic market is forecasted to grow by USD 537.8 million during 2023-2028, accelerating at a CAGR of 4.96% during the forecast period. The report on the kidney stones therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of flexible digital ureteroscopes, rising incidence of urolithiasis among the global population, and increasing prevalence of kidney stone disease.
The kidney stones therapeutic market is segmented as below:
By End-user
- Hospitals
- Specialty clinics
- Ambulatory surgical centers
By Type
- Lithotripsy
- Ureteroscopy
- Percutaneous nephrolithonomy (PCNL)
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the kidney stones therapeutic market covers the following areas:
- Kidney stones therapeutic market sizing
- Kidney stones therapeutic market forecast
- Kidney stones therapeutic market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global kidney stones therapeutic market: Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in technologies in kidney stones treatment."
According to the report, one of the major drivers for this market is the growing popularity of flexible digital ureteroscopes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Anvik Biotech
- Aristo Pharma GmbH
- Bausch Health Companies Inc.
- Bayer AG
- Biomedix Siomond Pharma
- Cipla Inc.
- Cmg Biotech Pvt. Ltd.
- Dr Reddys Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- GlaxoSmithKline Plc
- Intas Pharmaceuticals Ltd.
- Johnson and Johnson Services Inc.
- Macleods Pharmaceuticals Ltd.
- Medinova Diagnostic Services Ltd.
- Mission Pharmacal Co.
- Nostrum Pharmaceuticals LLC
- Pfizer Inc.
- Walter Bushnell
- Windlas Biotech Pvt. Ltd.
- Worth Medicines Pvt. Ltd.
